## Abstract Prostate carcinoma is one of the most common malignant tumors and has become a more common cancer in men. Previous studies demonstrated that evodiamine (EVO) exhibited antiβtumor activities on several cancers, but its effects on androgenβindependent prostate cancer are unclear. In the p
319 SYNERGISTIC EFFECT OF COMBINATION OF AZD6244 AND GSK2126458 ON CELL DEATH IN HUMAN PROSTATE CANCER DU145 CELL LINE
β Scribed by Park, Hongzoo; Kim, Yunlim; Hwang, Jung Jin; Kim, Choung-Soo
- Book ID
- 123331792
- Publisher
- Lippincott Williams and Wilkins
- Year
- 2013
- Tongue
- English
- Weight
- 52 KB
- Volume
- 189
- Category
- Article
- ISSN
- 0022-5347
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Experiments have been performed to clarify whether LHRH agonists might decrease growth of hormone-unresponsive prostate cancer in vivo. Male nude mice were injected s.c. with the human androgen-independent prostate tumor DU 145 cells; osmotic minipumps releasing the LHRH agonist Zoladex (LHRH-A) for
## Background: Targeting epigenetic events associated with autonomous growth of advanced prostate cancer (pca) is a practical approach for its control, prevention, and treatment. recently we showed that treatment of prostate carcinoma du145 cells with cancer preventive flavonoid silymarin at 100-20